Skip to content

Drug interactions

Glimepiride + Ivosidenib

Severity: Moderate

Glimepiride and Ivosidenib: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Ivosidenib can induce CYP2C9, which is the main pathway clearing glimepiride. Lower glimepiride exposure may lead to weaker glucose control and hyperglycemia.

What this interaction means in plain words

Glimepiride and Ivosidenib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Glimepiride belongs to Endocrine; Ivosidenib belongs to Oncology.

Evidence level: Moderate

Why it happens

Ivosidenib induces CYP2C9, increasing the metabolism of glimepiride.

What to do

Monitor blood glucose and HbA1c after starting or stopping ivosidenib and increase the glimepiride dose or add another agent if control worsens. Reduce the dose again if ivosidenib is discontinued to avoid hypoglycemia.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Glimepiride and Ivosidenib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Glimepiride with Ivosidenib?

MediHelp rates the interaction as moderate. Glimepiride and Ivosidenib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Ivosidenib can induce CYP2C9, which is the main pathway clearing glimepiride. Lower glimepiride exposure may lead to weaker glucose control and hyperglycemia.

How serious is the interaction between Glimepiride and Ivosidenib?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood glucose and HbA1c after starting or stopping ivosidenib and increase the glimepiride dose or add another agent if control worsens. Reduce the dose again if ivosidenib is discontinued to avoid hypoglycemia.

What other medicines interact with Glimepiride?

MediHelp also lists interactions of Glimepiride with, for example, Fluconazole, Insulin degludec-liraglutide, Insulin glargine-lixisenatide. The full list is on the Glimepiride page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in